PGM3 deficiency was first described in 2014 in patients with hyper-IgE syndrome phenotype characterized by recurrent infections, atopy, and elevated serum IgE [77, 78]. The gene discussed is IGHE; the disease is hyperinsulinemic hypoglycemia, familial, 4.